Cavity Protection Fresh Mint Anticavity Mouthwash

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the protection against dental cavities. It is designed to support oral health by reducing the risk of cavity formation in patients.

Dosage and Administration

Healthcare professionals are advised to instruct patients to shake the product well before use. The recommended administration involves vigorously swishing 1 to 2 capfuls of the solution in the mouth for a minimum duration of 1 full minute. Following the swishing, patients should refrain from rinsing, eating, or drinking for at least 5 minutes to ensure optimal efficacy of the treatment.

Contraindications

Use of this product is contraindicated in children under six years of age, unless specifically recommended by a dentist or physician. Additionally, the product should not be used if the safety seal is torn or missing, as this may compromise product integrity and safety.

Warnings and Precautions

It is imperative that this product is used solely for rinsing purposes and is not intended for ingestion. Healthcare professionals should advise patients to keep the product out of reach of children under six years of age. The use of this product in children under six should only occur if specifically recommended by a dentist or physician.

In the event that more than one ounce is accidentally swallowed, immediate medical attention should be sought by contacting a physician or the Poison Control Center.

Additionally, the product should not be used if the safety seal is found to be torn or missing, as this may indicate potential contamination or compromised integrity.

Side Effects

Patients should be aware of the following warnings and precautions associated with the use of this product. It is intended for rinsing only and should not be swallowed. In the event that more than one ounce is accidentally ingested, it is imperative to contact a physician or Poison Control Center immediately.

This product is not recommended for use by children under the age of six unless specifically advised by a dentist or physician. Additionally, the product should not be used if the safety seal is torn or missing, as this may compromise its safety and efficacy.

It is essential to keep this product out of reach of children to prevent accidental ingestion and potential harm.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Cavity Protection Fresh Mint Anticavity Mouthwash (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under six years of age should not use this product unless specifically recommended by a dentist or physician. It is important to keep the product out of reach of children in this age group. In the event that more than one ounce is accidentally swallowed, immediate contact with a physician or Poison Control Center is advised.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is no specific information available regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions that should be taken. Healthcare professionals are advised to consider the lack of data when prescribing this medication to pregnant patients. The potential risks and benefits should be carefully evaluated, and alternative treatments may be considered in consultation with the patient. Women of childbearing potential should be informed of the absence of established safety data during pregnancy.

Lactation

Lactating mothers should consult a physician before using this product. There is a potential for excretion in breast milk, and the effects on nursing infants are not well studied; therefore, caution is advised.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical attention is crucial. If more than one ounce of the substance is accidentally ingested, it is imperative to contact a physician or the Poison Control Center without delay.

Healthcare professionals should be aware that prompt intervention can significantly mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and monitoring for any signs of toxicity is essential.

Management procedures should include a thorough assessment of the patient's condition, including vital signs and any presenting symptoms. Supportive care may be necessary, and specific treatment protocols should be followed as per established guidelines for the substance in question.

In summary, swift action and appropriate medical guidance are vital in managing cases of overdosage to ensure patient safety and effective treatment outcomes.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients that this product is not to be used by children under six years of age unless specifically recommended by a dentist or physician. It is important for patients to understand the age restrictions to ensure safe usage.

Additionally, healthcare providers should inform patients that in the event of accidental ingestion of more than one ounce, they should contact a physician or the Poison Control Center immediately. This precaution is crucial for ensuring patient safety and prompt medical attention if necessary.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product away from direct sunlight to maintain its integrity and effectiveness. Proper storage conditions should be observed to ensure optimal quality.

Additional Clinical Information

The medication is administered orally, with the recommended method involving vigorous swishing of 1-2 capfuls for a minimum of one full minute. Patients should refrain from rinsing, eating, or drinking for five minutes following administration to ensure optimal effectiveness.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Cavity Protection Fresh Mint Anticavity Mouthwash, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)